We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesCipla Limited

Cipla Limited

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
1404.0 INR -15.90 ( 1.12%)
Last update at 2026-11-12T09:45:00Z
VOLUME
1640486
Market Cap
1183505.97M
P/E
21.74

Momentum Score

…

Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
1399.50
Low
1420.00
High
52 Week Price Range
1323.54
Low
1673.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
1419.90
Dividend Yield
-
Revenue TTM
279658.20M
Revenue Per Share
346.26
Gross Profit TTM
185980.60M
Debt / Equity
0.01
ROE
17.68%
Net Debt
-1492.60M
ROCE
19.21%
Diluted EPS TTM
67.38

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Income before tax 67989.60M 57003.10M 40383.50M 34932.70M 32900.60M
Minority interest 33.20M -321.70M -309.80M -299.00M 2590.60M
Net income 52725.20M 41215.50M 28019.10M 25167.50M 24048.70M
Selling general administrative 49446.70M 44026.90M 9281.40M 8119.70M 7051.90M
Selling and marketing expenses 11620.60M 10874.10M 16943.00M 16700.00M 12986.20M
Gross profit 180921.40M 164927.60M 142209.00M 124030.40M 109764.50M
Reconciled depreciation 11069.50M 10510.20M 11721.10M 10519.50M 10676.60M
Ebit 61291.20M 53494.40M 43303.10M 37240.40M 33749.50M
Ebitda 70221.40M 61906.70M 55024.20M 47141.20M 44426.10M
Depreciation and amortization 8930.20M 8412.30M 11721.10M 9900.80M 10676.60M
Operating income 105005.80M 94795.80M 40077.80M 35627.00M 32493.10M
Other operating expenses 167668.60M 160571.30M 186183.20M 180623.30M 157460.90M
Interest expense 620.10M 785.10M 1095.40M 1048.50M 1529.80M
Tax provision 15297.60M 15465.90M 12028.60M 9338.00M 8887.60M
Interest income 6303.40M 2195.90M 1095.40M 1063.50M 1607.00M
Net interest income -620.10M -898.80M -1095.40M -1063.50M -1607.00M
Income tax expense 15297.60M 15465.90M 12028.60M 9338.00M 8887.60M
Total revenue 272674.40M 255367.10M 224731.80M 216327.60M 189968.30M
Total operating expenses 75915.60M 70131.80M 103660.40M 88326.10M 77257.10M
Cost of revenue 91753.00M 90439.50M 82522.80M 92297.20M 80203.80M
Total other income expense net -37016.20M -37792.70M 279.70M -822.50M 279.60M
Net income from continuing ops 52692.00M 41537.20M 28328.90M 25466.50M 23885.10M
Net income applicable to common shares 52725.20M 41215.50M 28019.10M 25167.50M 24048.70M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 373870.40M 327178.20M 294632.80M 271011.20M 251518.90M
Intangible assets 17161.20M 16010.00M 15301.40M 17028.60M 18282.60M
Other current assets 15228.40M 16369.30M 8489.90M 88.00M 93.10M
Total liab 60977.90M 59152.90M 57497.40M 59837.40M 65663.00M
Total stockholder equity 311934.50M 267066.30M 234077.80M 208416.90M 183265.30M
Other current liab 24595.10M 24148.80M 2841.30M 461.50M 619.00M
Common stock 1615.20M 1616.70M 1614.30M 1613.60M 1612.90M
Capital stock 1615.20M 1614.70M 1614.30M 1613.60M 1612.90M
Retained earnings 287892.80M 245837.80M 180570.30M 156690.70M 135369.80M
Other liab - - - 4960.10M 5741.10M
Good will 32702.70M 31120.40M 29838.60M 31379.30M 30072.90M
Other assets 9525.50M 7000.80M 10412.90M 12452.90M 10627.70M
Cash 5886.90M 6400.70M 6276.30M 6777.40M 7932.90M
Cash and equivalents 116.70M 264.30M 837.30M 653.90M 1497.50M
Total current liabilities 54839.60M 52457.70M 51096.70M 49132.10M 45915.50M
Current deferred revenue 475.40M 1354.20M 17741.90M 18652.20M 18284.20M
Net debt -1492.60M -797.70M 1754.90M 3780.40M 12211.20M
Short term debt 1869.60M 3348.80M 5943.00M 4812.60M 6137.70M
Short long term debt 801.20M 2470.20M 5203.60M 4079.00M 3347.30M
Short long term debt total 4394.30M 5603.00M 8031.20M 10557.80M 20144.10M
Other stockholder equity 16926.00M 16728.40M 51893.20M 50112.60M 46282.60M
Property plant equipment 64750.20M 59332.90M 56799.50M 56087.20M 56488.60M
Total current assets 232885.20M 194414.10M 172749.50M 147275.40M 132095.10M
Net tangible assets - - - 160009.00M 134909.80M
Short term investments 100205.90M 71389.30M 61074.20M 39539.30M 23599.10M
Net receivables 55063.70M 47706.60M 45344.80M 47368.30M 53778.20M
Long term debt 119.80M 0.00M 0.00M 4162.40M 12027.50M
Inventory 56421.10M 52379.50M 51564.30M 53502.40M 46691.80M
Accounts payable 28374.90M 24739.80M 24570.50M 25205.80M 20874.60M
Accumulated other comprehensive income 5500.50M 2883.40M - - -
Non currrent assets other 17147.90M 14634.10M 9643.00M 8578.80M 8413.50M
Non current assets total 140985.20M 132764.10M 121883.30M 123735.80M 119423.80M
Capital lease obligations 3460.90M 3123.90M 2827.60M 2316.40M 2588.50M
Long term debt total 2524.70M 2254.20M 2088.20M 5745.20M 14006.40M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Investments -36911.40M -29880.30M -23885.10M 1525.70M -12586.30M
Change to liabilities - - - 3622.90M 2030.50M
Total cashflows from investing activities -36911.40M -29880.30M -23885.10M -18718.80M -23871.80M
Net borrowings -860.50M -3004.60M - -10983.30M -11678.50M
Total cash from financing activities -12927.90M -12004.30M -9582.90M -15997.90M -13299.00M
Net income 52725.20M 41215.50M 42207.70M 36753.90M 32900.60M
Change in cash 303.10M -489.90M -967.80M -1323.20M 509.10M
Begin period cash flow 5123.40M 5613.30M 6581.10M 7904.30M 7423.80M
End period cash flow 5426.50M 5123.40M 5613.30M 6581.10M 7932.90M
Total cash from operating activities 50049.80M 41339.10M 32376.50M 33259.00M 37552.00M
Issuance of capital stock 0.50M 0.40M 0.70M 27.00M 359.50M
Depreciation 11069.50M 9416.10M 11721.10M 9900.80M 10676.60M
Other cashflows from investing activities -361.80M 292.10M -12056.20M -13584.60M -3397.60M
Dividends paid 10498.30M 6861.70M -4035.00M -4033.50M 4033.50M
Change to inventory -3225.40M -618.60M 1107.70M -6211.10M -2543.20M
Change to account receivables -8018.70M -9069.50M -6519.80M 813.60M 4229.30M
Sale purchase of stock 0.50M 0.40M -5066.90M -1327.80M 4033.50M
Other cashflows from financing activities -1569.60M -2138.40M -42.70M -197.50M -2722.00M
Change to netincome - - - -34.70M -244.50M
Capital expenditures 11621.60M 13493.00M 11828.90M 7011.50M 8189.20M
Change in working capital -6654.70M -8061.00M -5594.20M -1774.60M 3716.60M
Stock based compensation 473.40M 461.60M 390.40M 241.20M 195.40M
Other non cash items -7563.60M -1693.10M -605.80M 90.00M 986.10M
Free cash flow 38428.20M 27846.10M 20547.60M 26247.50M 29362.80M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(INR)
Price
(INR)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
CIPLA
Cipla Limited		 -15.90
1.12%		 1404.00 21.74 19.01 4.23 3.76 4.08 14.00
SUNPHARMA
Sun Pharmaceutical Industries Limited		 -12.10
0.64%		 1890.20 40.32 26.95 7.69 5.50 7.41 23.64
DIVISLAB
Divi's Laboratories Limited		 83.00
0.73%		 11450.00 70.47 - 17.47 11.44 17.33 47.08
TORNTPHARM
Torrent Pharmaceuticals Limited		 -60.90
1.28%		 4700.10 63.48 56.50 11.13 16.39 11.65 35.91
DRREDDY
Dr. Reddy's Laboratories Limited		 11.00
0.80%		 1388.00 17.16 21.93 2.94 2.89 2.99 10.39

Profile*

Cipla Limited

Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.

Cipla House, Mumbai, India, 400013

91 22 2482 6000

https://www.cipla.com

30313

Name Title Year Born
Mr. Umang Vohra MD, Global CEO & Exec. Director 1971
Ms. Samina Hamied Exec. Vice-Chairperson 1976
Dr. Raju Sunil Mistry M.A., Ph.D. Pres & Global Chief People Officer 1965
Mr. Pradeep Bhadauria Pres & Chief Scientific Officer NA
Mr. Ashish Adukia Global Chief Financial Officer NA
Mr. Dinesh Ramniranjan Jain Sr. VP & Head of Corp. Fin. NA
Ms. Geena V. Malhotra Global Chief Technology Officer NA
Mr. Naveen Bansal Head of Investor Relations NA
Mr. Gautam Rohidekar Chief Legal Officer NA
Mr. Rajendra Kumar Chopra Compliance Officer & Company Sec. NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CJT
CAD 111.15
+12.71%
CLS
CAD 374.20
+8.33%
GRZ
CAD 4.90
+7.46%
CTC-A
CAD 218.05
+6.38%
FEC
CAD 7.42
+5.85%
TF
CAD 4.13
-19.65%
TLO
CAD 5.98
-15.06%
FSZ
CAD 2.45
-14.04%
XNDU
CAD 3.60
-8.86%
ITR
CAD 2.75
-8.50%

Equity Sectors*

  • Basic Materials

    -2.63%

  • Communication Services

    -0.79%

  • Consumer Cyclical

    +0.08%

  • Consumer Defensive

    -0.12%

  • Energy

    +0.52%

  • Financial Services

    -1.15%

  • Healthcare

    -1.74%

  • Industrials

    -0.64%

  • Real Estate

    -0.12%

  • Technology

    -0.51%

  • Utilities

    -0.02%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…